Small molecule inhibitors of PI3-kinase signaling

    公开(公告)号:US09701646B2

    公开(公告)日:2017-07-11

    申请号:US14777630

    申请日:2014-03-18

    CPC classification number: C07D249/06

    Abstract: Provided are certain 1,2,3-triazole and 1,2,3-triazole dimer analogs of DM-PIT-1 which are second-generation selective non-phosphoinositide small molecule inhibitors of phosphatidylinositol-3,4,5-trisphosphate (PIP3), including 1,2,3-triazoles represented by formula (I) where: Ar represents aryl or heteroaryl; X represents O or S; each of Ra, Rb, Rc, and Rd independently represents hydrogen, halogen, C1-C10alkyl, —OH, —CF3, aryl, amino, or nitro; and Ar is optionally substituted with one or more substituents independently selected from the group consisting of halogen, C1-C10alkyl, —OH, —CF3, amino, and nitro. Also provided are pharmaceutical compositions comprising compounds of the invention and a pharmaceutical carrier. Also provided are methods of inhibiting PIP3-mediated signaling in a cell and treating cancer using compounds of the invention.

    SMALL MOLECULE INHIBITORS OF PI3-KINASE SIGNALING
    3.
    发明申请
    SMALL MOLECULE INHIBITORS OF PI3-KINASE SIGNALING 有权
    小分子抑制剂PI3激酶信号通路

    公开(公告)号:US20160297777A1

    公开(公告)日:2016-10-13

    申请号:US14777630

    申请日:2014-03-18

    CPC classification number: C07D249/06

    Abstract: Provided are certain 1,2,3-triazole and 1,2,3-triazole dimer analogs of DM-PIT-1 which are second-generation selective non-phosphoinositide small molecule inhibitors of phosphatidylinositol-3,4,5-trisphosphate (PIP3), including 1,2,3-triazoles represented by formula (I) where: Ar represents aryl or heteroaryl; X represents O or S; each of Ra, Rb, Rc, and Rd independently represents hydrogen, halogen, C1-C10alkyl, —OH, —CF3, aryl, amino, or nitro; and Ar is optionally substituted with one or more substituents independently selected from the group consisting of halogen, C1-C10alkyl, —OH, —CF3, amino, and nitro. Also provided are pharmaceutical compositions comprising compounds of the invention and a pharmaceutical carrier. Also provided are methods of inhibiting PIP3-mediated signaling in a cell and treating cancer using compounds of the invention.

Patent Agency Ranking